You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,350,171


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,350,171 protect, and when does it expire?

Patent 10,350,171 protects CONSENSI and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 10,350,171
Title:Celecoxib and amlodipine formulation and method of making the same
Abstract: Provided herein is a celecoxib and amlodipine composition and method of making the same. The composition contains granules containing celecoxib. The amlodipine is incorporated into the composition as an extragranulate.
Inventor(s): Efrati; Yitshak Itsik (Modiin, IL)
Assignee: Dexcel Ltd. (Or-Akiva, IL) Kitov Pharmaceuticals (Tel Aviv, IL)
Application Number:16/008,538
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,350,171
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,350,171: A Comprehensive Guide

Introduction

When analyzing a patent, understanding its scope, claims, and position within the broader patent landscape is crucial for both the patent holder and competitors. This article will delve into the details of United States Patent 10,350,171, providing a thorough analysis of its claims, scope, and the surrounding patent landscape.

Understanding Patent Claims

Patent claims are the most critical part of a patent application, as they define the scope of the invention and what is protected by the patent. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to an independent claim[3].

Patent 10,350,171 Overview

To begin, let's identify the key elements of United States Patent 10,350,171.

Invention Description

This patent, like any other, describes a specific invention or innovation. The description includes the background of the invention, a detailed explanation of the invention, and drawings or diagrams that illustrate the invention.

Claims Analysis

The claims section is where the patent's legal boundaries are defined. Here, you will find both independent and dependent claims that outline what the patent protects.

  • Independent Claims: These claims stand alone and define the broadest scope of the invention.
  • Dependent Claims: These claims refer back to an independent claim and narrow down the scope, often adding specific details or limitations.

Scope of the Patent

The scope of a patent is determined by its claims. Here are some key points to consider:

Claim Coverage Matrix

A Claim Coverage Matrix can help in understanding which patents and claims are actively protecting the intellectual property. This matrix categorizes patents not only by claims but also by overarching scope concepts, allowing for a more comprehensive analysis of the patent landscape[3].

Scope Concepts

Scope concepts are powerful categorization tools that help in filtering, searching, and analyzing large numbers of patent claims. These concepts can be high-value, indicating immediate relevance; medium-value, suggesting potential future directions; or low-value, indicating less importance[3].

Patent Landscape Analysis

Analyzing the patent landscape involves understanding the broader context in which the patent exists.

Technical Field Classification

Patents are often classified into broad technology fields, such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, and a miscellaneous “Other” category. This classification helps in identifying where the patent fits within the larger technological landscape[1].

Geographical and Ownership Analysis

Patent data can be analyzed based on the location of the inventor or the ownership rights. This can provide insights into regional innovation patterns and the distribution of intellectual property rights[4].

Continuation and Family Allowance Rates

Understanding the continuation and family allowance rates can provide insights into the patent's prosecution history.

  • First-Action Allowance Rate: The proportion of progenitor applications allowed without further examination.
  • Progenitor Allowance Rate: The proportion of progenitor applications allowed without any continuation procedure.
  • Family Allowance Rate: The proportion of progenitor applications that produce at least one patent, including the outcomes of continuation applications[1].

Ex Parte Reexamination and Obviousness-Type Double Patenting (ODP)

In cases where patents are challenged, understanding the procedures and outcomes of ex parte reexamination and ODP is crucial.

  • Ex Parte Reexamination: This process allows for the reevaluation of a patent's validity based on prior art or other grounds. If a patent is found unpatentable, it can be invalidated[2].
  • ODP: This occurs when multiple patents claim the same invention or an obvious variation of it. Ensuring that patents do not fall under ODP is essential to maintain their validity[2].

Determining Inventorship

Correctly identifying the inventors is vital for the enforceability of the patent.

  • Conception and Reduction to Practice: In the U.S., invention involves the conception of the idea and its reduction to practice. Proper inventorship must be determined to ensure the patent remains enforceable[5].

Key Takeaways

  • Claims Are Critical: The claims section of a patent defines its legal boundaries and scope.
  • Scope Concepts: Using scope concepts helps in categorizing and analyzing patent claims efficiently.
  • Patent Landscape: Understanding the broader patent landscape, including technical field classification and geographical analysis, is essential.
  • Prosecution History: Analyzing continuation and family allowance rates provides insights into the patent's history.
  • Legal Challenges: Being aware of ex parte reexamination and ODP is crucial for maintaining patent validity.
  • Inventorship: Correctly determining inventorship is vital for the patent's enforceability.

FAQs

Q: What is the importance of independent claims in a patent? A: Independent claims define the broadest scope of the invention and stand alone without referencing other claims.

Q: How does a Claim Coverage Matrix help in patent analysis? A: A Claim Coverage Matrix categorizes patents by claims and scope concepts, making it easier to identify gaps or opportunities in intellectual property protection.

Q: What is the difference between first-action allowance rate and progenitor allowance rate? A: The first-action allowance rate is the proportion of applications allowed without further examination, while the progenitor allowance rate is the proportion allowed without any continuation procedure.

Q: Why is determining inventorship important for a patent? A: Correctly identifying inventors ensures the patent remains enforceable and avoids legal challenges related to improper inventorship.

Q: What is obviousness-type double patenting (ODP)? A: ODP occurs when multiple patents claim the same invention or an obvious variation of it, which can lead to the invalidation of the patents involved.

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent?. The Yale Journal of Law & Technology.
  2. In re Cellect, LLC, 22-1293, United States Court of Appeals for the Federal Circuit.
  3. Patent Analytics. Schwegman, Lundberg & Woessner, P.A.
  4. Invention, Knowledge Transfer, and Innovation. National Science Foundation.
  5. Determining Inventorship for US Patent Applications. Oregon State University.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,350,171

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Purple Biotech CONSENSI amlodipine besylate; celecoxib TABLET;ORAL 210045-001 May 31, 2018 DISCN Yes No 10,350,171 ⤷  Subscribe Y ⤷  Subscribe
Purple Biotech CONSENSI amlodipine besylate; celecoxib TABLET;ORAL 210045-002 May 31, 2018 DISCN Yes No 10,350,171 ⤷  Subscribe Y ⤷  Subscribe
Purple Biotech CONSENSI amlodipine besylate; celecoxib TABLET;ORAL 210045-003 May 31, 2018 DISCN Yes No 10,350,171 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,350,171

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 111065382 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2019008583 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.